Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Eur Urol. 2021 Jan 7;79(6):762–771. doi: 10.1016/j.eururo.2020.12.037

Table 1 –

Isolation platforms for CTCs in PC

Technology CTC definition Application in PC
Antibody-based positive selection
CellSearch EpCAM+, CD45−, CK8+, CK18+, CK19+, DAPI+ [57]
Adna Test EpCAM+, PSA+/PSMA+/EGFR+ [15]
CTC-Chip EpCAM+, specific antigen+ [89]
CTC-iChip >3.8 μm size, EpCAM+ [90]
IsoFlux CD45−, DAPI+, PanCK+, or EpCAM+ [91]
MagSweeper EpCAM+, CD45−, DAPI + [10,92]
CellCollector EpCAM+, CD45−, PanCK+, PSA+, Hoechst+ [74]
NanoVelcro EpCAM+, CD4−, PanCK+, morphological verification [93]
Antibody-based negative selection
EasySep CD45− [94]
RosetteSep CD45−, CD66b−, glycophorin A−, density [74]
EPISPOT CD45−, CD66b−, glycophorin A−, PSA+, FGF2+ [74]
CTC-iChip CD45−, CD16−, CD66b− [90]
Selection free
Epic Sciences PanCK+, CD45−, DAPI+, AR+ [9]
AccuCyte DAPI+, PanCK+, CD45−, CD66b−, CD11b−, CD14−, CD34−, EpCAM+ [95]
Physical properties
ApoStream Dielectrophoretic field flow [96]
Celsee Diagnostics >7.5 μm, deformability [97]
ISET ≥8 μm [95]

CTC = circulating tumor cell; EGFR = epidermal growth factor receptor; PC = prostate cancer; PSA = prostate-specific antigen; PSMA = prostate-specific membrane antigen.

Positive (+) and/or negative (−) expression of different capture/detection antigens, or physical properties, is used as a criterion for CTC isolation by different technologies or platforms.